Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Constronics Infra Ltd Stock Analysis

Small Cap
Evaluated by 41 users | BSE: 523844 | NSE: |
Hospital & Healthcare Services

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Capital Employed -16.3%-8.1%-5.16%-6.82%-6.81%-10.75%-12.14%-14.2%-20.17%-2.98%11.06%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 1.100.20000000.61.92
Y-o-Y Gr. Rt.--100%NA-100%NANANANANANA241.8%-
Adjusted EPS (Rs.) -0.57-0.13-0.07-0.09-0.08-0.12-0.12-0.13-0.18-0.030.13-0.02
Y-o-Y Gr. Rt.-NANANANANANANANANANA-
Book Value per Share (Rs.) 0.811.421.351.261.171.050.930.810.0300.130.03
Adjusted Net Profit -0.4-0.1-0.1-0.1-0.1-0.1-0.1-0.1-0.100.10
Net Op. Cash Flow (Rs. Cr.) -1.20-0.200000-0.1-0.10.1-
Debt to Cash Flow from Ops -0.570000000-5.24-8.028.87-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Constronics Infra Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales NANANA241.8%
Adjusted EPS NANANANA
Book Value per Share -23.3-34.2-45.70
Share Price -3.7% 28.2% 24.1% 77.1%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Equity (%) -51.75-11.44-5.2-6.86-6.88-10.77-12.17-14.42-42.43-171.88192.41-25
Operating Profit Margin (%) -50.990-27.84000000-4.065-0.95
Net Profit Margin (%) -37.650-27.43000000-4.124.95-0.7
Debt to Equity 1.13000000027.42436.148.456.5
Working Capital Days 43102,035000000614187115
Cash Conversion Cycle -1,124063000000048-
Loading price chart...
Entity Percentage Holding
Promoters 18.47%
Non-Institutions 81.53%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Constronics Infra Ltd's earnings have grown by 0%, whereas share price has appreciated 28.2% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.

Constronics Infra Ltd share price has declined -3.7% annually (CAGR) over the past ten years.

Data is not available for this company.

Invicta Meditek Limited (Invicta) incorporated in 1992 is a Public Limited company engaged in the manufacture of quality Orthopaedic Implants and Instruments.

Invicta Meditek manufacture the quality Orthopaedic Implants and Instruments. Invicta serves the field of Orthopaedics by supplying products for Total Joint Replacement systems, Trauma Implants and Associated Instruments. The product range also includes implants for Hemi-Arthroplasty, all types of Dynamic Compression and round hole

Invicta Meditek Limited (Invicta) incorporated in 1992 is a Public Limited company engaged in the manufacture of quality Orthopaedic Implants and Instruments.

Invicta Meditek manufacture the quality Orthopaedic Implants and Instruments. Invicta serves the field of Orthopaedics by supplying products for Total Joint Replacement systems, Trauma Implants and Associated Instruments. The product range also includes implants for Hemi-Arthroplasty, all types of Dynamic Compression and round hole plates, Screws with Cortical, Cancellous profiles, special thread sizes and in all diameters (with and without cannulation) and DHS/ DCS systems. The Joint Replacement Systems for Knee, Hip, Shoulder and Ankle are manufactured under license from Endotec Inc., USA.

Invicta has established a full-fledged machine shop with sophisticated, state of the art machinery required to meet the challenging, stringent quality requirements of the Orthopaedic implants and the high levels of accuracy required for the instruments used in joint replacement and other critical surgical operations.

Invicta lays special emphasis on achieving customer satisfaction by demonstrating the ability to consistently provide products that meet and exceed customer requirements. The Quality Control Department is equipped with the latest tools and instruments maintaining the strict quality standards demanded by the orthopaedic community.

Invicta’s product portfolio includes:-Total Joint Replacements for Knee, Hip, Ankle, Shoulder (under license from Endotec Inc., USA) -trauma implants (plates, screws, nails etc) -associated instrumentation

Product range of the company includes:

  • BP Hiflex Knee
  • Hip Implants
  • Trauma Implants
  • Conventional Implants
  • Instruments

Achievements/ recognition :

  • It is an ISO 13485-2003 & CE certified company.
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback